Rejuvenate Biomed, the NIHR Leicester BRC, and Wellcome Leap partner for Phase 2 Study in COPD-related sarcopenia

The Phase 2 double-blind placebo-controlled clinical trial will evaluate the potential of RJx-01 to maintain muscle integrity in older persons with severe acute exacerbation of COPD Rejuvenate Biomed anticipates commencing patient enrollment first half 2025 DIEPENBEEK, Belgium and LEICESTER, United Kingdom and LOS ANGELES, Oct. 28, 2024 (GLOBE NEWSWIRE) -- Rejuvenate Biomed, the University of Leicester, the National Institute for Health and Care Research (NIHR) Leicester Biomedical Research Centre (BRC), an ...